Treatment with a JAK inhibitor was found to alleviate symptoms in the small study of patients with disabling pansclerotic morphea, a rare, severe inflammatory skin disorder, first described in 1923.
The prevalence of actionable genes is similar across genomes of men from African, European, Asian, or mixed ancestry, suggesting that genomics alone can t account for racial disparities in outcomes.
A single injection every 3 months of a novel drug that targets the lipid metabolism enzyme ANGPTL3 resulted in substantial reductions in LDL cholesterol in patients with HoFH in the phase 2 GATEWAY trial.
After having her concerns dismissed by her doctor, a woman diagnosed with Hodgkin lymphoma partnered with the Lymphoma Research Foundation to spread the word about unique challenges facing patients.
A genetic predisposition for Alzheimer s disease has been associated with an increased risk for epilepsy, and vice versa, results of a large genome-wide association study (GWAS) show.